YUUTH Trademark

Trademark Overview

On Friday, February 11, 2022, a trademark application was filed for YUUTH with the United States Patent and Trademark Office. The USPTO has given the YUUTH trademark a serial number of 97263058. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, September 29, 2025. This trademark is owned by Ponce Therapeutics Inc.. The YUUTH trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders
yuuth

General Information

Serial Number97263058
Word MarkYUUTH
Filing DateFriday, February 11, 2022
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, September 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements

Goods and ServicesGene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePonce Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154
Party NamePonce Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022ASSIGNED TO EXAMINER
Tuesday, August 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2022NEW APPLICATION ENTERED
Wednesday, February 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 22, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 22, 2023SOU EXTENSION 1 FILED
Monday, May 22, 2023SOU EXTENSION 1 GRANTED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 21, 2024SOU EXTENSION 3 FILED
Tuesday, May 21, 2024SOU EXTENSION 3 GRANTED
Wednesday, May 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU TEAS EXTENSION RECEIVED
Sunday, May 11, 2025SOU EXTENSION 5 FILED
Monday, May 12, 2025SOU TEAS EXTENSION RECEIVED
Monday, September 29, 2025SOU EXTENSION 5 GRANTED
Monday, September 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU EXTENSION 4 GRANTED
Tuesday, May 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, November 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU EXTENSION 4 FILED

Related Keywords

yuuth other cancer related skin disorders treatment prevention therapy based pharmaceutical